Evaluation of the Utility of Hybrid PET/MR Neuroimaging in Inflammatory Demyelination and Encephalitis.

With the increased availability of hybrid PET/MRI in recent years, this method is increasingly used for neuroimaging in clinical practice. It combines the advantages of MRI (including high-resolution imaging of intracerebral lesions and data provided from specialised MRI sequences) with the benefits of PET, which visualises functional alterations in the brain, as well as assesses the myelin quantity changes and the severity of inflammation. The use of PET/MRI may help to eliminate the limitations of MRI indicated in imaging demyelinating inflammatory diseases (such as low specificity in imaging demyelination and a weak correlation of findings with clinical symptoms), as well as insufficient sensitivity in detecting lesions present in encephalitis. In addition to supporting the diagnosis of encephalitis, PET/MRI facilitates monitoring of the disease course and assessing the treatment efficacy of inflammatory demyelinating diseases and encephalitis, as well as evaluating the risk of multiple sclerosis relapse. Further multi-centre longitudinal studies are necessary to assess the real clinical potential of PET/MRI among patients with inflammatory demyelination or encephalitis. In addition to MS and AIE, these studies should also include other inflammatory demyelinating diseases (ADEM, NMO, NMOSD, and MOGAD) as well as encephalitis of viral and parasitic aetiology.